Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on July 7, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Supply of Z-SPEC Z-max XRF Instrument

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract entails the procurement of a Z-SPEC Z-max XRF instrument equipped with Doubly Curved Crystal (DCC) x-ray optics, specifically designed for the sensitive and accurate trace detection of lead and mercury in regulated commodities. This instrument is intended to enhance the FDA’s capacity for rapid, non-destructive elemental analysis in compliance and safety monitoring programs, ensuring adherence to regulatory standards for consumer products. The equipment’s advanced optics will enable improved detection limits and precision, critical for identifying hazardous contaminants at very low concentrations. The solicitation is issued as a subcontract under the Department of Health and Human Services, managed by the FDA Office of Acquisition and Grant Services, with performance required at a location in Irvine, California, 92612. The opportunity was posted on July 7, 2026, and responses must be submitted no later than July 14, 2026, at 2:00 PM. It is classified under NAICS code 334516, which pertains to the manufacturing of analytical laboratory instruments. There is no set-aside designator specified, and the contract is open to qualified vendors capable of delivering the specified instrumentation with full technical compliance and operational readiness.

General Info

Procurement of Z-SPEC Z-max XRF with DCC optics for trace lead and mercury detection in regulated products at Irvine, CA.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

334516 - Analytical Laboratory Instrument ManufacturingView NAICS

Place of Performance

Irvine, CA, 92612, USA

Set-Aside

NONE

Documents

This scope was carved out of NOI-FDA-133864.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Presolicitation Notice – Z-SPEC Z-max X-Ray Fluorescence (XRF) Instrument

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Procurement of a new Z-SPEC Z-max XRF instrument with Doubly Curved Crystal (DCC) x-ray optics for trace detection of lead and mercury in regulated commodities.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS